🇺🇸 FDA
Patent

US 8105805

High affinity human antibodies to human IL-18 receptor

granted A61PA61P1/00A61P19/02

Quick answer

US patent 8105805 (High affinity human antibodies to human IL-18 receptor) held by REGENERON PHARMACEUTICALS, INC. expires Mon Jan 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Jan 31 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61P, A61P1/00, A61P19/02, A61P25/00, A61P29/00